EE9700361A - Meetod silma närvi ja võrkkesta verevoolu kiiruse suurendamiseks - Google Patents

Meetod silma närvi ja võrkkesta verevoolu kiiruse suurendamiseks

Info

Publication number
EE9700361A
EE9700361A EE9700361A EE9700361A EE9700361A EE 9700361 A EE9700361 A EE 9700361A EE 9700361 A EE9700361 A EE 9700361A EE 9700361 A EE9700361 A EE 9700361A EE 9700361 A EE9700361 A EE 9700361A
Authority
EE
Estonia
Prior art keywords
retina
nerve
eye
increasing
flow rate
Prior art date
Application number
EE9700361A
Other languages
English (en)
Estonian (et)
Inventor
Eric Sponsel William
Harris Alon
Original Assignee
Advanced Research & Technology Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Research & Technology Institute filed Critical Advanced Research & Technology Institute
Publication of EE9700361A publication Critical patent/EE9700361A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EE9700361A 1995-05-22 1996-05-17 Meetod silma närvi ja võrkkesta verevoolu kiiruse suurendamiseks EE9700361A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/445,839 US5789435A (en) 1995-05-22 1995-05-22 Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight
PCT/US1996/007225 WO1996037203A1 (en) 1995-05-22 1996-05-17 Method to increase retinal blood flow

Publications (1)

Publication Number Publication Date
EE9700361A true EE9700361A (et) 1998-06-15

Family

ID=23770397

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700361A EE9700361A (et) 1995-05-22 1996-05-17 Meetod silma närvi ja võrkkesta verevoolu kiiruse suurendamiseks

Country Status (20)

Country Link
US (1) US5789435A (cs)
EP (1) EP0833632A1 (cs)
JP (1) JPH11503462A (cs)
KR (1) KR19990021853A (cs)
CN (1) CN1186019C (cs)
AU (1) AU703301B2 (cs)
BG (1) BG63148B1 (cs)
BR (1) BR9609297A (cs)
CA (1) CA2218549C (cs)
CZ (1) CZ289224B6 (cs)
EE (1) EE9700361A (cs)
HU (1) HUP9802553A3 (cs)
IS (1) IS4611A (cs)
NO (1) NO318600B1 (cs)
NZ (1) NZ308016A (cs)
RU (1) RU2181045C2 (cs)
SK (1) SK283960B6 (cs)
TR (1) TR199701406T1 (cs)
UA (1) UA48178C2 (cs)
WO (1) WO1996037203A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999000133A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
US6126037A (en) * 1997-09-09 2000-10-03 Merck & Co., Inc. Flow control orifice
WO1999030717A1 (en) * 1997-12-12 1999-06-24 Alcon Laboratories, Inc. Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow
DE69928771T2 (de) * 1998-01-23 2006-09-07 Einar Stefansson Carbonische anhydrase inhibitor zur steigerung des sauerstoffdrucks im sehnerv und retina
CA2323749A1 (en) * 1998-03-06 1999-09-10 William E. Sponsel Composition and method for treating macular disorders
WO2004073708A1 (en) 1998-12-17 2004-09-02 Dean Thomas R Brinzolamide and brimonidine for treating ocular conditions
JP4717996B2 (ja) * 2000-10-11 2011-07-06 サーパス工業株式会社 容器及びそれに用いるプラグ
US20040046934A1 (en) * 2002-02-14 2004-03-11 Board Of Regents, The University Of Texas System Oculokinetic offset acuity testing
RU2232582C2 (ru) * 2002-07-29 2004-07-20 Уфимский научно-исследовательский институт глазных болезней Глазная пленка
US20040242457A1 (en) * 2003-05-27 2004-12-02 Ashby Charles R. Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
MX2007011165A (es) * 2007-09-12 2009-03-11 Arturo Jimenez Bayardo Composición farmacéutica estable de timolol, dorzolamida y brimonidina.
US10363245B2 (en) 2017-02-22 2019-07-30 The Board Of Regents Of The University Of Texas System Methods for treating CNS lesions
WO2019108866A1 (en) 2017-12-03 2019-06-06 Natureworks Llc Polylactic resin compositions for paperboard coating and paperboard coating processes using the compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416890A (en) * 1981-07-13 1983-11-22 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4386098A (en) * 1981-11-03 1983-05-31 Merck & Co., Inc. 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4426388A (en) * 1982-04-02 1984-01-17 Merck & Co., Inc. 5-Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent

Also Published As

Publication number Publication date
BG63148B1 (bg) 2001-05-31
CN1186019C (zh) 2005-01-26
EP0833632A4 (cs) 1998-05-20
JPH11503462A (ja) 1999-03-26
AU5754096A (en) 1996-12-11
NO975330L (no) 1998-01-07
HUP9802553A2 (hu) 1999-04-28
BG102064A (en) 1998-07-31
HK1020166A1 (en) 2000-03-31
SK153597A3 (en) 1998-07-08
IS4611A (is) 1997-11-10
NZ308016A (en) 2000-09-29
NO318600B1 (no) 2005-04-18
KR19990021853A (ko) 1999-03-25
EP0833632A1 (en) 1998-04-08
RU2181045C2 (ru) 2002-04-10
UA48178C2 (uk) 2002-08-15
WO1996037203A1 (en) 1996-11-28
SK283960B6 (sk) 2004-06-08
TR199701406T1 (xx) 1998-03-21
CN1199336A (zh) 1998-11-18
HUP9802553A3 (en) 2002-01-28
CA2218549A1 (en) 1996-11-28
CZ289224B6 (cs) 2001-12-12
US5789435A (en) 1998-08-04
CA2218549C (en) 2005-09-20
MX9709063A (es) 1998-10-31
CZ369497A3 (cs) 1998-06-17
BR9609297A (pt) 1999-08-17
NO975330D0 (no) 1997-11-20
AU703301B2 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
EE9700361A (et) Meetod silma närvi ja võrkkesta verevoolu kiiruse suurendamiseks
NO992755L (no) Protese for oeyets senehinne for behandling av presbyopi og andre forstyrrelser i oeyner
FI970489A7 (fi) Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät dok sepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon
AU8072294A (en) Improved visualization of choroidal blood flow and aberrant vascular structures in the eye
AU7605396A (en) Cannula with associated filter and methods of use during cardiac surgery
ZA966319B (en) Corneal irrigation cannula
CA2231803A1 (en) Lipid extract having anti-inflammatory activity
FR2612918B1 (fr) Vitroceramique biocompatible, ne contenant pas d'alcalins, ou sont melanges de l'apatite, de la wollastonite et du diopside en cristaux
BR9402201A (pt) Solução oftálmica e método para tratar o olho contra irritação e secura
EP0253094A3 (en) Use of prostaglandin d2-active substances in the treatment of ocular hypertension and glaucoma
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
EP0801534A4 (en) OPTICAL DISPLAY OF BLOOD FLOW AND ABNORMAL VASCULAR STRUCTURES IN THE CORE OF THE EYE
IL118258A0 (en) Method of use of phthalocyanines to inactivate blood borne parasites
FR2599156B1 (fr) Iris fixe corrigeant la vue du myope et de l'hypermetrope
EP1024810A4 (en) METHOD FOR OPTIMIZING RETINAL AND THE HEALTH OF THE OPTICAL NERVE
NZ291053A (en) Method to maximise the health of the optic nerve and retina by using a beta-adrenergic blocking agent
WO2001043697A3 (en) Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
AU5430894A (en) Diagnosis of eye disorders
FI954675A7 (fi) Luonnollinen ja terveellinen mehu, yhdistelmä välttämättömistä ravinto aineista kehon toimintaa varten
FI953622A0 (fi) Ifenprodiilin ja sen diastereoisomeerien käyttö lääkeaineiden valmistukseen, jotka lääkeaineet ovat käyttökelpoisia perifeeristen neuropatiatilojen ja keskushermoston degeneratiivisten sairauksien hoitoon
AU7940794A (en) Pneumatic helmet for massage and stimulation of the blood irrigation of the head
RU95111665A (ru) Способ фиксации составного мостовидного протеза
RU93034430A (ru) Способ лечения негнойных заболеваний уха
IT1298215B1 (it) Metodo educativo per superare la dislessia collegata a predominanza dell'occhio sinistro (mancinismo oculare) e sussidio ottico per
IS4278A (is) Aðferð til að örva blóðfrumumyndun með blóðrauða